Trans-activator of transcription (Tat)/Envelope glycoprotein (gp120) intracranial administration in rodents has been used to define certain aspects of neuronal damage related to pediatric HIV-1 infection [40,41]. This evidence concerns the gene TAT and HIV-1 infection.